146 Evolving Mutliplexed shRNA to generate tailored CAR T cell therapy

• David Gilham,
• Hannes Iserentant,
• Eytan Breman,
• Fanny Huberty,
• Nancy Ramelot,
• Mikhail Steklov,
• Benjamin Lecalve,
• Jerome Marijse,
• Celine Jacques-Hespel

Affiliations

David Gilham

Aff4 grid.462482.e0000000404170074Clinical and Experimental Immunotherapy Group, Institute of Cancer SciencesManchester Academic Healthcare Science Centre Manchester United Kingdom

Hannes Iserentant

10VIB, Zwijnaarde, Belgium

Eytan Breman

Celyad Oncology, Mont-Saint-Guibert, Belgium

Fanny Huberty

Celyad Oncology, Mont-Saint-Guibert, Belgium

Nancy Ramelot

Celyad Oncology, Mont-Saint-Guibert, Belgium

Mikhail Steklov

Celyad Oncology, Mont Saint Guibert, Belgium

Benjamin Lecalve

Celyad Oncology, Mont Saint Guibert, Belgium

Jerome Marijse

Celyad Oncology, Mont Saint Guibert, Belgium

Celine Jacques-Hespel

Celyad Oncology, Mont Saint Guibert, Belgium